Protocols›Longevity & bioregulator›Longevity Foundations
← Protocols
Athlete / performance · uptakeCommunity · convergenceNo approved clinical use

Longevity Foundations

Stack: Epitalon · NAD/NMN · GHK-Cu — the baseline ageing stack
"The combination people reach for first when the goal is 'ageing' rather than a single fix — a pineal bioregulator, an NAD precursor and a copper repair tripeptide run together. Each part has some human data on its own; the three-as-a-stack has none. Convention, not proof."
GoalLongevity / cellular maintenance
Compounds3 · Epitalon · NAD/NMN · GHK-Cu
Humans exposed (est.)High — undocumented
StatusMHRA (UK): none is a licensed medicine — Epitalon & GHK-Cu sold as research material; NMN sold as a supplement (legal to buy) · FDA (US): NMN not a lawful dietary-supplement ingredient (2022 ruling); Epitalon & GHK-Cu not approved
In this stack — snapshot; tap through for the full molecule file
Provenance & evidence layers — of the combination, not the parts
Longevity / biohacker convention
Where / who
Longevity, anti-ageing and biohacker communities — the default "baseline ageing stack" people assemble before targeting anything specific.
Use status
All three are widely used; running them together is community convention, not a documented regimen.
Evidence it adds
Popularity / convention — not efficacy of the combination.
Basis: real-world uptake & convention — not trial data
Per-compound human data
NAD/NMN
Has the strongest individual base: multiple randomised human trials of oral NMN on NAD+ levels and metabolic markers — generally well-tolerated, with modest and contested functional effects.
GHK-Cu
Decades of human topical-cosmetic data (skin, wound, collagen). Systemic/injected longevity use is extrapolated from in-vitro and gene-expression work, not human anti-ageing trials.
Epitalon
Russian clinical literature (Khavinson group) reports longevity and telomere effects; small, mostly single-centre, rarely independently replicated to Western trial standards.
What it means
Some real human evidence on the parts — strongest for NMN, weakest for Epitalon. None of it tests the three together.
Basis: per-compound trials — see each molecule page
No approved clinical use
Clinical record
No country lists this combination — or any single part — as an approved longevity therapy.
Human trials
No completed human trial of the combination. Stack-level evidence is absent.
Basis required for a clinical-use tag: none found — absence shown, not hidden
Regulatory — read carefully
MHRA (UK)
None is a licensed medicine. Epitalon & GHK-Cu are sold as research material; NMN is sold legally as a food supplement.
FDA (US)
FDA ruled NMN is not a lawful dietary-supplement ingredient (2022). Epitalon & GHK-Cu are not approved drugs.
What it means
UK-legal-to-buy (NMN as supplement) is not the same as proven or quality-controlled.
Why it matters
No marketing authorisation = no pharmacovigilance; adverse events aren't formally tracked.
Basis: MHRA supplement framework · FDA NMN ruling (2022)
Why this combination

Epitalon, NAD/NMN and GHK-Cu are stacked because each targets a different ageing lever — pineal/telomere signalling, cellular NAD+ supply, and copper-dependent repair/collagen respectively — so the convention is "cover several mechanisms at once" rather than push one hard. That logic is mechanistic and plausible; it is not backed by any trial of the three run together. The strongest individual evidence sits with NMN; the weakest with Epitalon.

Members only · the actionable depth
See exactly how it's run
Doses, cycle structure and what to monitor are part of membership. The provenance, evidence and exposure above are always free.
Start 30 days free →
No card needed · cancel anytime
Cycle shape — how it's typically structured, not a schedule to follow
Loading
build up
Maintenance
hold / taper
Off
stop / reassess
Convention from community use, not a prescription.
What's worth monitoring

There is no validated marker set for this combination, but a longevity stack is one where baseline bloods are most worth having — metabolic panel, fasting glucose/HbA1c and lipids give NMN something to read against, and a clinician conversation matters before adding injected compounds (Epitalon, GHK-Cu) on top of a supplement. Limited combination safety data is a reason for more caution, not less. General information, not medical advice.

Combination evidence
Real-world uptake High

A default baseline stack in longevity and biohacker circles.

Best-supported part NMN

Randomised human trials on NAD+ and metabolic markers — modest, contested effects.

Combination efficacy None

No human trial tests Epitalon + NAD/NMN + GHK-Cu together.

The honest ceiling

Plausible mechanisms, some data on the parts, nothing on the whole. A reasonable baseline to read about — not a proven longevity intervention.

Fast facts
Compounds

Epitalon · NAD/NMN · GHK-Cu

Humans exposed (est.)

High — undocumented.

UK strip

GREEN — NMN supplement; Epitalon & GHK-Cu research material